U.S. Pharma Stock News

Hagerty stock triggered review Hagerty (HGTY) has drawn investor attention after its latest reported figures showed annual revenue of US$1.46b and net income of US$38.68m. This has prompted closer scrutiny of its recent share performance and business mix. See our latest analysis for Hagerty. At a share price of US$10.70, Hagerty has seen pressure in the year to date, with an 18.63% year to date share price decline and an 11.86% 90 day share price decline, even though the 1 year total...

In April 2026, Westinghouse Air Brake Technologies (Wabtec) reported first-quarter 2026 results showing revenue of US$2,950 million and net income of US$362 million, while reaffirming 2026 revenue guidance of US$12.19 billion to US$12.49 billion and completing a US$1.46 billion share repurchase program begun in February 2024. The combination of higher earnings per share from continuing operations and ongoing capital returns through buybacks and dividends highlights management’s confidence in...

nVent Electric recently highlighted its expanding role in power transmission, distribution, and data center infrastructure, following a series of acquisitions and the divestiture of certain thermal management brands to sharpen its focus. This tighter portfolio, especially around data center cooling and integrated electrical solutions, positions nVent to address rising power demand and large-scale capacity buildouts across utilities and digital infrastructure. Now we’ll examine how nVent’s...

Recently released data showing a rise in US pending home sales has signaled renewed momentum in the housing market, supporting sentiment toward digital real estate platforms such as Opendoor Technologies. This pickup in buyer activity through online channels highlights how Opendoor’s transaction-focused model is closely tethered to shifts in underlying housing demand. We’ll now examine how strengthening pending home sales, and the related housing demand signals, may influence Opendoor...

Earlier this week, Phillips Edison & Company, Inc. raised its 2026 net income guidance to US$0.79–US$0.81 per share after reporting first-quarter revenue of US$190.74 million and net income of US$30.38 million, both higher than a year ago. The stronger outlook, underpinned by growth in funds from operations and a leased portfolio occupancy of 97.1%, reinforces the resilience of its grocery-anchored retail centers. Next, we’ll examine how the upgraded 2026 earnings guidance reshapes Phillips...

Root, Inc. and Carvana recently announced that their exclusive embedded program, Carvana Insurance Built with Root, has surpassed 200,000 policies sold across 36 states, reflecting deep technical integration between Carvana’s e-commerce platform and Root’s digital-first insurance capabilities. This milestone highlights how embedding a 3-click, point-of-sale insurance option into Carvana’s online car-buying journey can deepen customer engagement and broaden the company’s higher-margin...

Cencora overview and recent share performance Cencora (COR) has drawn investor attention after a period of mixed share performance, with the stock showing a 1 day return of 1.03%, a 7 day decline of 4.59%, and a past 3 months decline of 13.46%. Over a longer horizon, Cencora has a 1 year total return of 7.87%, a 3 year total return that is very large, and a 5 year total return of 1.62x, with the shares last closing at US$308.19. See our latest analysis for Cencora. Recent share price moves...

PTC Inc. recently showcased how Bobcat uses its integrated CAD, PLM, service, and AI-enabled lifecycle solutions to streamline compact excavator development and operations at Hannover Messe 2026 in Hannover, Germany. The event highlighted PTC’s ability to connect cloud-native, AI-driven tools across design, manufacturing, and service, underscoring its role in real-world digital transformation for manufacturers like Bobcat and ProGlove. Next, we’ll examine how PTC’s AI-enabled Intelligent...

Why Illumina’s latest software launch matters for shareholders Illumina (ILMN) has put its DRAGEN v4.5 software release and a large pediatric genomics data partnership at the center of its story, tying product upgrades directly to real world precision medicine projects. See our latest analysis for Illumina. The software launch and pediatric data partnership come as Illumina’s share price trades at US$127.88, with a 30 day share price return of 8.68%, a 90 day share price return of 15.92% and...

What recent performance says about Grupo Aeroméxico. de (AERO) With no single headline event driving attention, readers are focusing on how Grupo Aeroméxico. de (AERO) has traded recently, including a month gain of 8.3% but a past 3 months decline of 28.7%. Over the past week the stock has dropped 9.3%, even as the latest session closed slightly higher at US$14.97. Year to date, shares are down 31.8%, which may prompt closer review of current valuation. See our latest analysis for Grupo...

Recent developments in the digital payment and e-commerce sectors highlight a significant increase in fraud, with global e-commerce fraud losses projected to more than double from $40 billion in 2024 to over $100 billion by 2029. This surge is attributed to rising transaction volumes, identity fraud, social engineering, and crypto scam escalations. Artificial intelligence is playing a dual role by facilitating more sophisticated attacks while also enhancing fraud detection tools. As fraud...

DaVita recently reported that its integrated kidney care platform reached profitability earlier than expected, supported by stable operations and a focus on value-based care that improves clinical outcomes for patients with chronic kidney disease. This early profitability milestone highlights how DaVita’s integrated care model can turn complex, outcomes-focused contracts into a financially sustainable part of its kidney-care ecosystem. We’ll now examine how this earlier-than-expected...

Earnings beat and dividend decision set the tone First BanCorp (FBP) has put fresh numbers on the table, pairing its first quarter 2026 earnings release with an updated capital return picture that includes dividends and recent share repurchases. Net interest income for the quarter came in at US$220.96 million compared to US$212.40 million a year earlier, while net income was US$88.78 million compared to US$77.06 million. Basic and diluted earnings per share from continuing operations were...

Event context and recent share performance Albany International (AIN) shares recently closed at $55.32, with the stock showing a one-month gain of 8.83%, a three-month decline of 2.21%, and a one-year total return decline of 15.29%. See our latest analysis for Albany International. The recent one month share price return of 8.83% contrasts with a 1 year total shareholder return decline of 15.29%. This suggests that short term momentum has picked up after a weaker multi year experience. If...

Recent performance context for WSFS Financial WSFS Financial (WSFS) has attracted attention after recent trading, with the stock last closing at $71.39 and posting gains of 1.8% over the past week and 12.5% over the past month. See our latest analysis for WSFS Financial. The recent 12.5% 1 month share price return and 29.7% year to date share price return sit alongside a 38.3% 1 year total shareholder return, which may suggest momentum is building rather than fading. If you are curious about...

Nektar Therapeutics recently completed a follow-on equity offering of about US$325.00 million and later closed an underwritten public offering totaling US$373.80 million, while reporting 52-week Phase 2b REZOLVE-AA data showing rezpegaldesleukin improved hair regrowth outcomes versus placebo in severe-to-very-severe alopecia areata with a favorable safety profile. The combination of strengthened funding and statistically significant 52-week efficacy for rezpegaldesleukin positions Nektar to...

Why SkyWest’s latest earnings matter for investors SkyWest (SKYW) just posted Q1 2026 results with US$1,013.18 million in revenue and US$101.69 million in net income, alongside active CRJ450 and E175 fleet plans and ongoing share repurchases. See our latest analysis for SkyWest. Even with Q1 results and fleet plans in focus, the share price has recently come under pressure, with a 1 day share price return of 7.18% decline and a year to date share price return of 14.93% decline. The 3 year...

What Recent Performance Says About Fortive (FTV) Without a specific news catalyst, Fortive (FTV) still gives investors a few concrete data points to work with, including recent share price moves and headline fundamentals that help frame current sentiment. See our latest analysis for Fortive. At a recent share price of US$61.09, Fortive’s 30 day share price return of 13.3% and 90 day return of 14.9% suggest momentum has been building, while the 1 year total shareholder return of 18.4% points...

Synaptics stock performance and recent returns Synaptics (SYNA) has drawn fresh investor attention after recent trading, with the share price closing at US$93.86 and posting a 10.5% move over the past day and a 13.0% change across the past week. See our latest analysis for Synaptics. The recent 36.6% 1 month share price return and 23.9% year to date share price return have come on top of a 66.8% 1 year total shareholder return, hinting that sentiment has strengthened after a weaker multi year...

TEN Ltd. recently announced that it has extended charter agreements for two DP2 shuttle tankers for up to five years each, starting after their current 15‑year contracts expire around mid‑2028, with the new deals expected to generate over US$200 million in gross revenues. This extension underscores the importance of long-term shuttle tanker employment in securing consistent cash flows and reinforcing relationships with major oil customers. Next, we’ll examine how locking in over US$200...

What the new buyback and dividend mean for Stanley Black & Decker (SWK) investors Stanley Black & Decker (SWK) just paired a fresh US$500 million share repurchase authorization with an affirmed US$0.83 quarterly dividend, replacing its prior buyback plan and putting capital returns back in focus. See our latest analysis for Stanley Black & Decker. At a share price of US$76.64, Stanley Black & Decker has a 30 day share price return of 11.36%, while its 1 year total shareholder return of 31.06%...

Rapport Therapeutics (RAPP) put its lead epilepsy candidate RAP-219 in the spotlight at the American Academy of Neurology 2026 meeting, pairing a formal presentation with detailed follow-up Phase 2a data. See our latest analysis for Rapport Therapeutics. The latest AAN data arrive after a strong run in the stock, with a 30 day share price return of 31.32% and a year to date share price return of 30.06%. The 1 year total shareholder return sits at 221.27%, which may indicate that investors are...

The United States market has remained flat over the last week, yet it has seen a significant 30% increase over the past year with earnings anticipated to grow by 16% annually. In this environment, identifying stocks that are potentially undervalued can be crucial, especially when insider activity may indicate confidence in their future prospects.

Why PureCycle Is Back on Investors’ Radar PureCycle Technologies (PCT) has drawn fresh attention after Abundance Wealth Counselors added about 6.7 million shares and the company secured a European Union grant for a new polypropylene recycling facility in Belgium. See our latest analysis for PureCycle Technologies. The fresh EU grant and large institutional purchase are landing at a time when momentum has been mixed, with a 37.69% 1 month share price return but a 35.89% 3 month share price...